HSIANG-KUANG LIANGWEN-YIH TSENG2020-03-032020-03-0320180167-8140https://www.scopus.com/inward/record.uri?eid=2-s2.0-85040529400&doi=10.1016%2fj.radonc.2017.12.014&partnerID=40&md5=cddb5f8b21cf676d7745669951708bbchttps://scholars.lib.ntu.edu.tw/handle/123456789/468669[SDGs]SDG3biological marker; epidermal growth factor receptor; isocitrate dehydrogenase 1; isocitrate dehydrogenase 2; methylated DNA protein cysteine methyltransferase; phosphatidylinositol 3 kinase; phosphatidylinositol 3,4,5 trisphosphate 3 phosphatase; protein p53; adverse outcome; brain edema; cancer prognosis; cancer survival; chromosome 19q; chromosome 1p; chromosome deletion; corpus callosum; gene amplification; gene mutation; glioblastoma; human; Letter; preoperative period; priority journal; protein methylation; subventricular zone; tumor invasionResponse to ‘Perilesional edema in brain cancer: Independent prognosticator or epiphenomenon of biomolecular signature?’journal article10.1016/j.radonc.2017.12.014293434082-s2.0-85040529400